PEOPLE - Sequenom makes appointment:
This article was originally published in Clinica
Executive Summary
Sequenom (San Diego, California), a developer of genetic analysis products, has appointed Steven Owings as vice president of commercial development. The priority focus of this newly-created position is commercialisation of the firm's first noninvasive pre-natal test. Mr Owings' 28 years in the diagnostics and biotech fields include stints at Roche Diagnostic Systems, Digene and Visible Genetics (part of Bayer Diagnostics since 2002). He joins from molecular diagnostics company Primagen (Georgia), where he was president of the North America division.